Sanofi Sa

Sanofi: Information concerning the total number of voting rights and shares - March 2026

Press Release: Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria

Sanofi becomes market authorization holder for Nuvaxovid® in Canada, expanding COVID-19 vaccine choices for Canadians

Sanofi - Combined General Meeting of April 29, 2026 - Availability of Preparatory documents

Press Release: Sanofi’s lunsekimig met primary and key secondary endpoints in phase 2 respiratory studies in asthma and CRSwNP